New treatment targets in osteoporosis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Joint, bone, spine : revue du rhumatisme

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jbspin.2010.02.004PMID 20381400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

  2010cited by this paper
• Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis).

  2010cited by this paper
• Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

  2010cited by this paper
• Single‐Dose, Randomized, Double‐Blind, Placebo‐Controlled Study of ACE‐011 (ActRIIA‐IgG1) in Postmenopausal Women

  2009cited by this paper
• Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva.

  2009cited by this paper
• Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

  2009cited by this paper
• Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density

  2009cited by this paper
• Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

  2009cited by this paper
• Activation of β‐Catenin Signaling in Articular Chondrocytes Leads to Osteoarthritis‐Like Phenotype in Adult β‐Catenin Conditional Activation Mice

  2009cited by this paper
• The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.

  2008cited by this paper
• A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity

  2008cited by this paper
• Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.

  2008cited by this paper
• Cathepsin K Inhibitors: A Novel Target for Osteoporosis Therapy

  2008cited by this paper
• Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial.

  2008cited by this paper
• Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

  2008cited by this paper
• DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation*

  2008cited by this paper
• Two‐Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

  2007cited by this paper
• The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics.

  2007cited by this paper
• Osteoclasts: what do they do and how do they do it?

  2007cited by this paper
• Novel osteoclast signaling mechanisms

  2007cited by this paper
• Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.

  2007cited by this paper
• Bone mass is inversely proportional to Dkk1 levels in mice.

  2007cited by this paper
• Future Anti‐Catabolic Therapeutic Targets in Bone Disease

  2006cited by this paper
• Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II.

  2006cited by this paper
• Denosumab in postmenopausal women with low bone mineral density.

  2006cited by this paper
• Regulation of bone mass by Wnt signaling.

  2006cited by this paper
• The role of the immune system in the pathophysiology of osteoporosis

  2005cited by this paper
• Effect of L-000845704, an αVβ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women

  2005cited by this paper
• Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

  2005cited by this paper
• Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling*

  2005cited by this paper
• Unoccupied αvβ3 Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal

  2005cited by this paper
• Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal.

  2005cited by this paper
• Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

  2005cited by this paper
• Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.

  2004cited by this paper
• A Single‐Dose Placebo‐Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

  2004cited by this paper
• Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway.

  2004cited by this paper
• The Chloride Channel Inhibitor NS3736 Prevents Bone Resorption in Ovariectomized Rats Without Changing Bone Formation

  2004cited by this paper
• Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

  2003cited by this paper
• Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

  2003cited by this paper
• Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling*

  2002cited by this paper
• Sex steroids and the construction and conservation of the adult skeleton.

  2002cited by this paper
• Cloning and characterization of the murine beta(3) integrin gene promoter: identification of an interleukin-4 responsive element and regulation by STAT-6.

  2001cited by this paper
• Cloning and characterization of the murine β3 integrin gene promoter: Identification of an interleukin‐4 responsive element and regulation by STAT‐6

  2001cited by this paper
• Anoikis mechanisms.

  2001cited by this paper
• The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

  2000influential reference
• Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.

  2000cited by this paper
• T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

  2000cited by this paper
• Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis

  2000cited by this paper
• T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

  2000cited by this paper
• Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.

  1999cited by this paper
• Determination of Bone Markers in Pycnodysostosis: Effects of Cathepsin K Deficiency on Bone Matrix Degradation

  1999cited by this paper
• Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.

  1998cited by this paper
• A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

  1997cited by this paper
• Characterization and Cellular Distribution of the Osteoclast Ruffled Membrane Vacuolar H+‐ATPase B‐Subunit Using Isoform‐Specific Antibodies

  1997cited by this paper
• Molecular mechanisms of bone resorption: therapeutic implications.

  1996cited by this paper
• Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

  1996cited by this paper
• Molecular mechanisms of bone resorption

  1995cited by this paper
• Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

  1991cited by this paper
• Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts

  1990cited by this paper
• Osteoclastic bone resorption by a polarized vacuolar proton pump.

  1989cited by this paper

• Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption

  2025cites this paper
• The Role of Osteoporosis in Spine Surgery and Current Management Strategies: A Review

  2025cites this paper
• Preparation, Identification and Screening of Anti-Osteoporosis Milk-Derived Peptides: Intervention Effects in Osteoporosis Rats

  2024cites this paper
• Treatment Strategies in the Osteoporotic Spine.

  2024cites this paper
• Insights into the Mechanism of Osteoporosis and the Available Treatment Options.

  2023cites this paper
• Multitarget-Based Virtual Screening for Identification of Herbal Substances toward Potential Osteoclastic Targets

  2022cites this paper
• Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women

  2021cites this paper
• the The Effect of Four Months of TRX Training on Lumbar Bone Mineral Density and its Relationship with Serum Adiponectin Level in Osteopenic Women

  2021cites this paper
• Rab GTPases in Osteoclastic Bone Resorption and Autophagy

  2020cites this paper
• Pharmacologic considerations in patients with osteoporosis undergoing lumbar interbody fusion: A systematic review.

  2020cites this paper
• Osteoporosis and Spine Surgery: A Critical Analysis Review.

  2020cites this paper
• Less influence of body mass index on bone mineral density of radius as compared to proximal femur: Possible role in the diagnosis of osteoporosis

  2020cites this paper
• Treatment of Osteoporosis: Current Scenario from a Research Perspective

  2019influential citation
• Proliferation Analysis of Cissus Quadrangular is and Cardiospermum Sp . on MG 63 Cell Line

  2019cites this paper
• Two novel peptides from ark shell protein stimulate osteoblast differentiation and rescue ovariectomy-induced bone loss.

  2019cites this paper
• Preventing Pseudoarthrosis and Proximal Junctional Kyphosis: How to Deal with the Osteoporotic Spine.

  2018cites this paper
• Estrogen therapy associated with mechanical vibration improves bone microarchitecture and density in osteopenic female mice

  2018cites this paper
• Orthosiphon stamineus (Misai Kucing) ameliorated postmenopausal osteoporosis in rat model

  2017cites this paper
• Proteome analysis of human serum proteins adsorbed onto different titanium surfaces used in dental implants

  2017cites this paper
• Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice

  2016cites this paper
• Loss of Sfrp2 in the Niche Amplifies Stress‐Induced Cellular Responses, and Impairs the In Vivo Regeneration of the Hematopoietic Stem Cell Pool

  2016cites this paper
• enopause du CHU d'Amiens

  2016cites this paper
• The Pharmacological Potential of Rutin

  2016cites this paper
• evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis

  2015cites this paper
• Évaluation du respect des recommandations de la haute autorité de santé pour la prescription d'une densitométrie osseuse chez les patientes de la consultation ménopause du CHU d'Amiens

  2015cites this paper
• Impact des nouvelles recommandations du traitement médicamenteux de l’ostéoporose post-ménopausique. Étude rétrospective des patientes vues en consultation « ostéoporose » entre 2006 et 2012

  2015cites this paper
• evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis

  2015cites this paper
• Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis

  2015cites this paper
• Perioperative Medical Management of Spine Surgery Patients With Osteoporosis.

  2015cites this paper
• Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche

  2014cites this paper
• Effects of Watercress Containing Rutin and Rutin Alone on the Proliferation and Osteogenic Differentiation of Human Osteoblast-like MG-63 Cells

  2014cites this paper
• Local treatment of osteoporosis with alendronate‐loaded calcium phosphate cement

  2014cites this paper
• Interleukin-10 Inhibits Bone Resorption: A Potential Therapeutic Strategy in Periodontitis and Other Bone Loss Diseases

  2014cites this paper
• Wnt and the Wnt signaling pathway in bone development and disease.

  2014cites this paper
• Simultaneous determination of strontium ranelate and aspartame in pharmaceutical formulation for the treatment of postmenopausal osteoporosis by capillary zone electrophoresis

  2014cites this paper
• The regulation of the sclerostin gene and the catabolic effects of sclerostin protein on bone.

  2014cites this paper
• Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: comparisons and current controversies.

  2013cites this paper
• Osteoimmunology and the infl uence of pro-infl ammatory cytokines on osteoclasts

  2013cites this paper
• Highly selective aza-nitrile inhibitors for cathepsin K, structural optimization and molecular modeling.

  2013cites this paper
• Modulation Of Renin Secretion By Renal Cortical Interstitial Calcium

  2013cites this paper
• Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts

  2013cites this paper
• Mechanisms of osteoclast-dependent bone formation.

  2013cites this paper
• Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures.

  2013cites this paper
• Therapeutic approaches to myeloma bone disease: an evolving story.

  2012cites this paper
• Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis

  2012cites this paper
• Classificação e fisiopatologia da osteoporose

  2012cites this paper
• Forsteo Observational Study ( EFOS ) 18-month follow-up of Greek women completing teriparatide treatment for osteoporosis

  2012cites this paper
• The effects of the histone deacetylase inhibitor, LBH589, on breast cancer in bone and on physiological bone remodelling.

  2012cites this paper
• Renin-Angiotensin-Aldosterone System Hypercalcemia Reduces Plasma Renin via Parathyroid Hormone, Renal Interstitial Calcium, and the Calcium-Sensing Receptor

  2011cites this paper
• N-acetyl-L-cysteine enhances the osteogenic differentiation and inhibits the adipogenic differentiation through up regulation of Wnt 5a and down regulation of PPARG in bone marrow stromal cells.

  2011cites this paper
• Osteoporozda Yeni Tedavi Ajanları

  2011cites this paper
• Genetic variation in the LDL receptor-related protein 5 (LRP5) gene : Association with bone health and metabolic parameters

  2011cites this paper
• Promising developments in osteoporosis treatment

  2011cites this paper
• Synthesis of substituted triazolyl curcumin mimics that inhibit RANKL-induced osteoclastogenesis.

  2011cites this paper
• Presente y futuro de los anticuerpos monoclonales en el tratamiento de la osteoporosis

  2011cites this paper
• N-acetyl-L-cysteine enhances the osteogenic differentiation and inhibits the adipogenic differentiation through up regulation of Wnt 5 a and down regulation of PPARG in bone marrow stromal cells

  2011cites this paper
• Kalzium-Sensing-Rezeptor-Antagonisten

  2011influential citation
• New Agents for the Treatment of Osteoporosis Osteoporozda Yeni Tedavi Ajanlari

  2011cites this paper
• [Present and future of the treatment of osteoporosis with monoclonal antibodies].

  2011cites this paper
• Hypercalcemia Reduces Plasma Renin via Parathyroid Hormone, Renal Interstitial Calcium, and the Calcium-Sensing Receptor

  2011cites this paper
• Strategies of spinal fusion on osteoporotic spine.

  2011cites this paper
• New Agents for the Treatment of Osteoporosis

  2011cites this paper
• Avancées thérapeutiques : nouvelles molécules, nouvelles stratégies

  2010cites this paper
• Bone Turnover Markers

  2010cites this paper
• [Advances treatment of osteoporosis: new molecules, new strategies].

  2010cites this paper
• Clinical Interventions in Aging Dovepress Bisphosphonate Use and Hip Fracture Epidemiology: Ecologic Proof from the Contrary

  year unknowncites this paper